相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study
Vincenzo Russo et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Direct Oral Anticoagulants in Octogenarians With Atrial Fibrillation: It Is Never Too Late
Vincenzo Russo et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2019)
Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight
So-Ryoung Lee et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Real-life Performance of Edoxaban in Elderly Patients With Atrial Fibrillation: a Multicenter Propensity Score-Matched Cohort Study
Vincenzo Russo et al.
CLINICAL THERAPEUTICS (2019)
Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation
Giuseppe Patti et al.
AMERICAN JOURNAL OF MEDICINE (2019)
Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial
Giuseppe Boriani et al.
EUROPEAN HEART JOURNAL (2019)
Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study
Tze-Fan Chao et al.
CIRCULATION (2018)
Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data
Edward W. Gregg et al.
LANCET (2018)
Mortality in COPD patients according to clinical phenotypes
Rafael Golpe et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2018)
Increased risk of major bleeding in underweight patients with atrial fibrillation who were prescribed non-vitamin K antagonist oral anticoagulants
Chan Soon Park et al.
HEART RHYTHM (2017)
Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes ORBIT-AF Registry
Justin B. Echouffo-Tcheugui et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta-analysis
K. Boonyawat et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Trials
Marco Proietti et al.
STROKE (2017)
Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub-Analysis From the PREFER in AF (PREvention oF Thromboembolic Events-European Registry in Atrial Fibrillation)
Giuseppe Patti et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence
Vincenzo Russo et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2017)
Current Status and Outcomes of Direct Oral Anticoagulant Use in Real-World Atrial Fibrillation Patients - Fushimi AF Registry
Yugo Yamashita et al.
CIRCULATION JOURNAL (2017)
The non-vitamin K antagonist oral anticoagulants (NOACs) and extremes of body weight-a systematic literature review
Raffaele De Caterina et al.
CLINICAL RESEARCH IN CARDIOLOGY (2017)
Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation Trial)
Somasekhara R. Balla et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
Body mass index is associated with prognosis in Japanese elderly patients with atrial fibrillation: an observational study from the outpatient clinic
Satoshi Yanagisawa et al.
HEART AND VESSELS (2016)
Causes of Death in Anticoagulated Patients With Atrial Fibrillation
Antonio Gomez-Outes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Prediction of atrial fibrillation development and progression: current perspectives
Konstantinos Vlachos et al.
WORLD JOURNAL OF CARDIOLOGY (2016)
The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis
Chatree Chai-Adisaksopha et al.
BLOOD (2014)
Worldwide Epidemiology of Atrial Fibrillation A Global Burden of Disease 2010 Study
Sumeet S. Chugh et al.
CIRCULATION (2014)
Estimation of the impact of warfarin's time-in-therapeutic range on stroke and major bleeding rates and its influence on the medical cost avoidance associated with novel oral anticoagulant use-learnings from ARISTOTLE, ROCKET-AF, and RE-LY trials
Alpesh Amin et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2014)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
A 12-Year Follow-up Study of Patients With Newly Diagnosed Lone Atrial Fibrillation Implications of Arrhythmia Progression on Prognosis: The Belgrade Atrial Fibrillation Study
Tatjana S. Potpara et al.
CHEST (2012)
Body Mass Index and Long-Term Mortality in an Elderly Mediterranean Population
Maria Victoria Zunzunegui et al.
JOURNAL OF AGING AND HEALTH (2012)
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation The Euro Head Survey
Ron Pisters et al.
CHEST (2010)
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation
Gregory Y. H. Lip et al.
CHEST (2010)
A catalogue of reporting guidelines for health research
I. Simera et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
Progression From Paroxysmal to Persistent Atrial Fibrillation Clinical Correlates and Prognosis
Cees B. de Vos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Age as a Risk Factor for Stroke in Atrial Fibrillation Patients Implications for Thromboprophylaxis
Ricarda Marinigh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation
Daniel E. Singer et al.
ANNALS OF INTERNAL MEDICINE (2009)
A Bayesian approach to evaluating net clinical benefit allowed for parameter uncertainty
AJ Sutton et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2005)
Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study
JK Lunceford et al.
STATISTICS IN MEDICINE (2004)
Atrial fibrillation in the elderly - Facts and management
G Chatap et al.
DRUGS & AGING (2002)
Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation
BF Gage et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
AS Go et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
分享论文
